Georgia Developers Back Push for Permit-Plat Shot Clocks
Georgia builders press a new plan to cap final plat review times, aiming to cut carrying costs and speed housing deli...
Ways Students Can Earn Money Fast
Learn the best ways students can earn money fast with quick income solutions. Start boosting your finances today.
27,906 articlesMAGY Magnificent Seven Income ETF Expands Monday Payouts
MAGY, the MAGY Magnificent Seven Covered Call ETF, now offers a Monday-morning income payout. The fund uses an active...
Déjà Bitcoin Tumbles Below as MicroStrategy Slumps Again
Bitcoin slipped below the $59,000 level for the first time in almost two years, intensifying a risk-off mood as Micro...
Crypto Lending Turns Wall Street Rules to Win Back Trust
A new credit framework aims to turn crypto lending into a Wall Street–style, on-chain process to win back institutions.
Missed Historic SpaceX IPO? SPCX Still a Buy Today
SpaceX burst onto Nasdaq in June 2026 and has since cooled, but SPCX's size, market reach, and looming index inclusio...
America Added More Than 1,200 Millionaires Daily in 2025
In 2025, the United States produced a surge of new millionaires, averaging roughly 1,200 per day. The trend lifted th...
Broadcom Nvidia: The $100B AI Chips Race Heats Up Globally
Broadcom and NVIDIA released staggered AI-focused results, spotlighting two distinct paths to a $100B AI sales target...
Strategy Bought Time: Bitcoin’s Next Cycle Needs Buyers
Strategy unveiled a broad capital-management package to steady its Bitcoin-buying strategy, but analysts say the next...
QYLD’s $10,000 Problem: Covered-Call Costs vs Nasdaq Gains
Investors chasing steady monthly income via QYLD face a trade-off: the cost of covered-call income can outpace Nasdaq...
Rambus Tailwinds Here’s Still: Stock Neutral on AI Wave
Rambus rides AI infrastructure tailwinds but keeps a neutral stance as investors weigh valuation against accelerating...
Beazer Fight Over Standstill Intensifies as Bid Climbs
Beazer Homes faces a pivotal moment as Dream Finders increases its cash bid to $32 per share, intensifying the beazer...
Johnson Johnson AbbVie: Paths to Pharma Dominance
Johnson & Johnson and AbbVie report divergent quarterly results, fueling a debate about two paths to pharma dominance...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status